Tumor-infiltrating lymphocytes (TILs) and genomic signatures of immune cells

被引：0
|
作者：
Denkert, C. [1 ]
机构：
[1] Charite, Berlin, Germany
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-ES4-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES4-3
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TUMOR-INFILTRATING LYMPHOCYTES AS ANTITUMOR EFFECTOR-CELLS
    WHITESIDE, TL
    BIOTHERAPY, 1992, 5 (01) : 47 - 61
  • [42] Tumor-infiltrating lymphocytes (TILs) and PDL1 expression in lung cancer brain metastases
    Berghoff, A. S.
    Cansu, I.
    Rajky, O.
    Ricken, G.
    Widhalm, G.
    Dieckmann, K.
    Birner, P.
    Oberndorfer, F.
    Dome, B.
    Bartsch, R.
    Zielinski, C.
    Preusser, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S593 - S593
  • [43] Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study
    Sonia Y. Khan
    Michael W. Melkus
    Fahmida Rasha
    Maribel Castro
    Victoria Chu
    Luis Brandi
    Hafiz Khan
    Harvinder Singh Gill
    Kevin Pruitt
    Rakhshanda Layeequr Rahman
    Annals of Surgical Oncology, 2022, 29 : 2914 - 2925
  • [44] Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes
    Ciarka, Aleksandra
    Piatek, Michal
    Peksa, Rafal
    Kunc, Michal
    Senkus, Elzbieta
    BIOMEDICINES, 2024, 12 (04)
  • [45] Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinomain situ
    Farolfi, Alberto
    Petracci, Elisabetta
    Serra, Luigi
    Ravaioli, Alessandra
    Bravaccini, Sara
    Ravaioli, Sara
    Tumedei, Maria Maddalena
    Ulivi, Paola
    Canale, Matteo
    Puccetti, Maurizio
    Falcini, Fabio
    Folli, Secondo
    Curcio, Annalisa
    Rocca, Andrea
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [46] Prognostic value of tumor-infiltrating lymphocytes (TILs) and expression of PD-L1 in cholangiocarcinoma
    Suleiman, Yaman
    Coppola, Domenico
    Zibadi, Sherma
    Dalia, Samir
    Juan, TzuHua
    Lee, Jae K.
    Malafa, Mokenge Peter
    Soliman, Hatem Hussein
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [47] Prediction of the treatment response to eribulin chemotherapy in breast cancer using tumor-infiltrating lymphocytes (TILs)
    Shinichiro, Kashiwagi
    Asano, Yuka
    Goto, Wataru
    Kurata, Kento
    Morisaki, Tamami
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Tanaka, Sayaka
    Ohsawa, Masahiko
    Ohira, Masaichi
    Hirakawa, Kosei
    CANCER RESEARCH, 2016, 76
  • [48] Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
    Pooja M. Vaid
    Anirudha K. Puntambekar
    Nutan S. Jumle
    Rituja A. Banale
    Danish Ansari
    Ruhi R. Reddy
    Rohini R. Unde
    Namrata P. Namewar
    Devaki A. Kelkar
    L. S. Shashidhara
    Chaitanyanand B. Koppiker
    Madhura D. Kulkarni
    Diagnostic Pathology, 17
  • [49] Clinicopathologic and genomic correlates of tumor-infiltrating immune cells and immunotherapy efficacy in NSCLC.
    Alessi, Joao Victor Machado
    Ricciuti, Biagio
    Nishino, Mizuki
    Weirather, Jason L.
    Le, Ann-Elisabeth
    Lindsay, James
    Sharma, Bijaya
    Felt, Kristen
    Sholl, Lynette M.
    Rodig, Scott J.
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Identification of receptor tyrosine kinases (RTKs) expression in tumor-infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells (PBMC)
    Khochenkov, Dmitry
    Volkova, Maria
    Tsimafeyeu, Ilya
    CANCER RESEARCH, 2017, 77
12345